68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients
European Journal of Nuclear Medicine and Molecular Imaging · 2025-09 · 52 (11) · 3963-3974
DOI: 10.1007/s00259-025-07239-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 24.04.2025. Verfasst von Lena M Unterrainer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Urinary Bladder Neoplasms, Cystectomy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwig-Maximilians-Universität München.
Abstract (Originalsprache)
Introduction
To determine the best therapeutic strategy for muscle-invasive bladder cancer (BC), the accuracy of lymph node staging is of paramount importance. However, diagnostic performance of conventional computed tomography in BC prior to radical cystectomy (RC) remains unsatisfactory. There is an increased interest in evaluating 18 F-FAPI PET/CT for hybrid imaging due to their logistical advantages compared to [ 68 Ga]Ga-based FAPI tracers in clinical routine. Recently, the potential diagnostic value of [ 68 Ga]Ga-FAPI- 46 PET/CT was demonstrated in BC. Thus, we aimed to examine the diagnostic performance of [ 18 F]F-FAPI- 74 and [ 68 Ga]Ga-FAPI- 46 PET/CT for preoperative evaluation of locoregional lymph node metastases.
Methods
Fifty-one patients underwent FAPI PET/CT with either [ 68 Ga]Ga-FAPI- 46 ( n = 23) or [ 18 F]F-FAPI- 74 ( n = 28) prior to RC and PLND. SUV max , SUV mean and the ratio between the SUV max of lymph nodes and the SUV mean of the background (SUV max_lymph node /SUV mean _ background ) were assessed. Additionally, short axis diameter (SAD) for a representative lymph node were documented in each lymph node region ( n = 123) and compared to histopathological findings. Each scan was interpreted visually and quantitatively. ROC-analyses were performed to determine cut-off values with highest diagnostic accuracy.
Results
20/123 (16.3%) lymph node regions showed UC lymph node metastases. Histopathologically positive lymph nodes were associated with a significantly higher FAPI uptake compared to negative lymph nodes regarding SUV max , SUV mean values and SUV max_lymph node /SUV mean _ background ratios. Visual analysis based on FAPI uptake showed a sensitivity and specificity, PPV and NPV of 63.6%, 95.8%, 77.7%, and 92.0% for [ 68 Ga]Ga-FAPI- 46 and 55.5%, 98.1%, 83.3%, and 93.1% for [ 18 F]F-FAPI- 74, respectively. ROC analysis revealed an optimal cut-off for SUV max , SUV mean and SUV max_lymph node /SUV mean _ background of 1.35, 1.20 and 5.95 for [ 68 Ga]Ga-FAPI- 46 and 1.55, 1.25 and 4.15 for [ 18 F]F-FAPI- 74 to discriminate between histopathologically proven lymph node metastases and non-malignant lymph nodes resulting for example using SUV max in a sensitivity and specificity, PPV and NPV of 81.8%, 89.5%, 64.2%, 95.5% for [ 68 Ga]Ga-FAPI- 46 and 100%, 81.8%, 47.3%, 100% for [ 18 F]F-FAPI- 74, respectively. CT visual analysis of locoregional lymph nodes showed a sensitivity, specificity, PPV and NPV of 30.0%, 97.0%, 66.6% and 87.7%, respectively. ROC analysis regarding SAD revealed a cutoff at 0.8 cm with a sensitivity, specificity, PPV and NPV of 75.0%, 84.4%, 48.3%, 94.5%, respectively.
Conclusion
Overall, FAPI PET imaging shows a significantly higher sensitivity than CT analysis for detection of locoregional lymph node metastases in UC. [ 18 F]F-FAPI- 74 demonstrates a comparable diagnostic performance compared to [ 68 Ga]Ga-FAPI- 46. Of note, the quantitative analysis with a pre-defined SUV max as well as SUV mean values, and SUV max_lymph node /SUV mean _ background ratio-based cut-offs provided a higher sensitivity compared to visual assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
- Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, Germany.
- Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California los Angeles, Los Angeles, CA, USA.
- Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. Hans.Schmid@med.uni-muenchen.de.
- Department of Urology, Krankenhaus Barmherzige Brüder, Munich, Germany.
- Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
ORCID-Profile: Hans P Schmid
Förderung
- Ludwig-Maximilians-Universität München
Zitieren
APA
Unterrainer, L. M., Schmid, H. P., Kunte, S. C., Holzgreve, A., Toms, J., Menold, P., Cyran, C. C., Karl, A., Tschirdewahn, S., Ledderose, S. T., Eismann, L., Tamalunas, A. J., Scheifele, M., Stief, C. G., Unterrainer, M., Casuscelli, J., & Schulz, G. B. (2025). 68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients. European Journal of Nuclear Medicine and Molecular Imaging, 52(11), 3963-3974. https://doi.org/10.1007/s00259-025-07239-6
Vancouver
Unterrainer LM, Schmid HP, Kunte SC, Holzgreve A, Toms J, Menold P, et al. 68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(11):3963-3974. doi:10.1007/s00259-025-07239-6
BibTeX
@article{Unterrainer2025,
author = {Unterrainer, Lena M and Schmid, Hans P and Kunte, Sophie C and Holzgreve, Adrien and Toms, Johannes and Menold, Paula and Cyran, Clemens C and Karl, Alexander and Tschirdewahn, Stephan and Ledderose, Stephan T and Eismann, Lennert and Tamalunas, Alexander J and Scheifele, Maximilian and Stief, Christian G and Unterrainer, Marcus and Casuscelli, Jozefina and Schulz, Gerald B},
title = {68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {52},
number = {11},
pages = {3963--3974},
doi = {10.1007/s00259-025-07239-6}
}
EUVIMED